You Are Here: Home > About Arthritis > Arthritis in the News


    Apply Filters Clear All
    supplement news article

    Jan 08

    AbbVie Receives Health Canada Approval of new oral RA Medication RINVOQ® (upadacitinib) Inflammatory forms of arthritis can be aggressive, and in the absence of a cure, medication can play a vital role in the treatment plan,. Patients and their physicians need access to a variety of treatment options. The Arthritis Society welcomes the approval of new treatments that expand the...
    supplement news article

    Jul 04

    1 in 4 medical cannabis users say it's now harder to access cannabis since recreational legalization According to a recent survey jointly commissioned by Canadians for Fair Access to Medical Marijuana (CFAMM), the Arthritis Society and the Canadian Pharmacists Association (CPhA), access issues are just one of the unintended consequences of recreational cannabis legalization affecting medical...
    supplement news article

    Apr 25

    Spectrum Cannabis, Arthritis Society Team Up to Launch Arthritis Talks, A National Symposium Series for Patients Spectrum Cannabis, the medical division of Canopy Growth Corporation, is pleased to announce a partnership with the Arthritis Society to raise awareness and educate people about living with arthritis, including the potential of medical cannabis as a treatment for arthritis symptoms and the...
    supplement news article

    Jun 07

    Addition of Cosentyx® to drug plans across Canada expands access to treatment Several provinces will now reimburse Cosentyx® (secukinumab) under the province's public drug program for eligible adults with PsA and AS.
    supplement news article

    Mar 06

    Promising New Findings on Using Biologic Drugs Before and During Pregnancy New research from British Columbia suggests that biologics are safe to use before and during pregnancy to treat automimune diseases, such as arthritis.
    supplement news article

    Feb 06

    Quebec adds Erelzi™ (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases Quebec is the most recent province to have added Erelzi to its formulary of exception drugs covered by the province's Public Prescription Drug Insurance Plan for the treatment of multiple inflammatory diseases.
    Load More